#boston-scientific
Latest news and interesting information about boston-scientific.
Wolfe Research Downgrades Boston Scientific
Wolfe Research downgraded Boston Scientific to Peer Perform as PFA and Watchman growth falter. Analyst sees 7% growth in 2027, stock in low $50s.
Piper Sandler Reiterates Boston Scientific Buy Rating
Piper Sandler reiterated an Overweight rating on Boston Scientific. Agent DCB drives growth; stock undervalued per Bond.az.
...

